Between the initial visit and during the 12 months follow-up, the IL-17A levels decreased significantly after the treatment, similar to qPCR parasitemia measurements (Kruskal-Wallis test; P<0.0001) (Fig 6b, S5 Fig). Here, IL17A is linked to parasitic infectious disease.